Novavax Inc (NVAX)
8.715
+0.04
(+0.40%)
USD |
NASDAQ |
Dec 20, 16:00
8.72
0.00 (0.00%)
After-Hours: 20:00
Novavax Total Liabilities (Quarterly): 2.239B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Moderna Inc | 3.876B |
| Inovio Pharmaceuticals Inc | 33.52M |
| Baxter International Inc | 18.73B |
| Halozyme Therapeutics Inc | 1.665B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.712B |
| Shareholders Equity (Quarterly) | -526.44M |
| Debt to Equity Ratio | -0.3215 |
| Current Ratio | 0.9345 |
| Net Debt Paydown Yield | -0.02% |